Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 16 von 5005

Details

Autor(en) / Beteiligte
Titel
Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrrioxamine (desferoxamine) in rat liver homogenates
Ist Teil von
  • Journal of pharmacy and pharmacology, 2001-10, Vol.53 (10), p.1393-1401
Ort / Verlag
Oxford, UK: Blackwell Publishing Ltd
Erscheinungsjahr
2001
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • The pharmacological effects of melatonin, vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) alone and in combination on iron‐induced membrane lipid damage in rat liver homogenates were examined by estimating levels of malondialdehyde and 4‐hydroxyalkenals (MDA + 4‐HDA). Individually, melatonin (2.5–1600 μM), vitamin E (0.5–50 μM), glutathione (100–7000 μM) and desferrioxamine (1–8 μM) inhibited lipid peroxidation in a concentration‐dependent manner. Vitamin C had both a pro‐oxidative (25–2000 μM) and an antioxidative (2600–5000 μM) effect. The IC50 (concentration that reduces damage by 50%) values were 4, 10, 426, 2290 and 4325 μM for vitamin E, desferrioxamine, melatonin, glutathione and vitamin C, respectively. The synergistic actions of melatonin with vitamin C, vitamin E, and glutathione were systematically investigated. When melatonin was combined with vitamin E, glutathione, or vitamin C, the protective effects against iron‐induced lipid peroxidation were dramatically enhanced. Even though melatonin was added at very low concentrations, it still showed synergistic effects with other antioxidants at certain concentrations. Furthermore, melatonin not only reversed the pro‐oxidative effects of vitamin C, but its efficacy in reducing lipid peroxidation was improved when it was combined with prooxidative concentrations of vitamin C. The results provide new information in terms of the possible pharmacological use of the combination of melatonin and classical antioxidants to treat free radical‐related conditions.
Sprache
Englisch
Identifikatoren
ISSN: 0022-3573
eISSN: 2042-7158
DOI: 10.1211/0022357011777747
Titel-ID: cdi_crossref_primary_10_1211_0022357011777747
Format

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX